Oncosil Medical Ltd (OSL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.814x

Based on the latest financial reports, Oncosil Medical Ltd (OSL) has a cash flow conversion efficiency ratio of -1.814x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.96 Million ≈ $-4.93 Million USD) by net assets (AU$3.84 Million ≈ $2.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Oncosil Medical Ltd (OSL) liquidity interval to measure how many days the company can operate on defensive assets alone.

Oncosil Medical Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Oncosil Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Oncosil Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosil Medical Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Torrent Capital Ltd V:TORR	0.075x
Speedvalue Ltd TA:SPDV	0.085x
Kuk Young G&M Co. Ltd KQ:006050	0.009x
Inbest Prime III Inmuebles SOCIMI S.A. MC:YINB3	N/A
Kko International SA PA:ALKKO	-0.098x
Nixxy, Inc. NASDAQ:NIXX	-0.096x
Effnetplattformen Holding AB ST:EFFH	-0.125x
SIXTY NORTH GOLD MIN.LTD. F:2F40	-0.020x

Annual Cash Flow Conversion Efficiency for Oncosil Medical Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Oncosil Medical Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Oncosil Medical Ltd (OSL) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$3.10 Million ≈ $2.20 Million	AU$-12.06 Million ≈ $-8.53 Million	-3.887x	-70.07%
2024-06-30	AU$4.74 Million ≈ $3.35 Million	AU$-10.82 Million ≈ $-7.66 Million	-2.285x	-99.55%
2023-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-11.32 Million ≈ $-8.01 Million	-1.145x	-26.45%
2022-06-30	AU$11.16 Million ≈ $7.90 Million	AU$-10.11 Million ≈ $-7.15 Million	-0.906x	-20.17%
2021-06-30	AU$11.70 Million ≈ $8.28 Million	AU$-8.82 Million ≈ $-6.24 Million	-0.754x	-270.43%
2020-06-30	AU$21.90 Million ≈ $15.50 Million	AU$-4.46 Million ≈ $-3.15 Million	-0.203x	+71.04%
2019-06-30	AU$10.68 Million ≈ $7.55 Million	AU$-7.50 Million ≈ $-5.31 Million	-0.703x	-51.92%
2018-06-30	AU$18.15 Million ≈ $12.85 Million	AU$-8.40 Million ≈ $-5.94 Million	-0.463x	+23.27%
2017-06-30	AU$10.13 Million ≈ $7.17 Million	AU$-6.11 Million ≈ $-4.32 Million	-0.603x	-95.27%
2016-06-30	AU$14.81 Million ≈ $10.48 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.309x	-1155.70%
2015-06-30	AU$6.96 Million ≈ $4.93 Million	AU$-171.16K ≈ $-121.11K	-0.025x	+96.33%
2014-06-30	AU$9.52 Million ≈ $6.73 Million	AU$-6.37 Million ≈ $-4.51 Million	-0.669x	-758.32%
2013-06-30	AU$6.05 Million ≈ $4.28 Million	AU$-471.91K ≈ $-333.90K	-0.078x	+36.67%
2012-06-30	AU$2.48 Million ≈ $1.76 Million	AU$-305.78K ≈ $-216.36K	-0.123x	-13.30%
2011-06-30	AU$2.91 Million ≈ $2.06 Million	AU$-316.67K ≈ $-224.06K	-0.109x	-281.54%
2010-06-30	AU$2.58 Million ≈ $1.82 Million	AU$154.35K ≈ $109.21K	0.060x	+346.60%
2009-06-30	AU$4.28 Million ≈ $3.03 Million	AU$-103.97K ≈ $-73.57K	-0.024x	+95.45%
2008-06-30	AU$4.09 Million ≈ $2.89 Million	AU$-2.18 Million ≈ $-1.54 Million	-0.533x	-85.54%
2007-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.35 Million ≈ $-952.00K	-0.288x	-902.55%
2006-06-30	AU$5.46 Million ≈ $3.86 Million	AU$195.51K ≈ $138.34K	0.036x	+278.21%
2005-06-30	AU$899.56K ≈ $636.50K	AU$-18.08K ≈ $-12.80K	-0.020x	--

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices

Market Cap

$13.28 Million

AU$18.77 Million AUD

Market Cap Rank

#26344 Global

#1221 in Australia

Share Price

AU$0.80

Change (1 day)

+34.75%

52-Week Range

AU$0.39 - AU$1.99

All Time High

AU$1.99